![Michael Tarnok](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tarnok
Direktor/Vorstandsmitglied bei
Ionetix, Inc.
Vermögen: 295 085 $ am 31.07.2026
Profil
Michael P.
Tarnok is currently Director at Ionetix, Inc. Formerly, Mr. Tarnok was Chairman at Keryx Biopharmaceuticals, Inc. from 2010 to 2016, Director at Global Health Council, Inc., Independent Director at Dyadic International, Inc. from 2024 to 2025, and Senior Vice President-Finance at Pfizer Inc. from 1989 to 2007.
Mr. Tarnok earned an MBA from New York University and completed undergraduate studies at St. John's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.06.2025 | 281’033 ( 0.77% ) | 295 085 $ | 31.07.2026 |
Aktive Positionen von Michael Tarnok
| Unternehmen | Position | Beginn |
|---|---|---|
Ionetix, Inc. | Direktor/Vorstandsmitglied | - |
Ionetix Corp.
 Ionetix Corp. Pharmaceuticals: OtherHealth Technology Manufactures radioisotopes and radiopharmaceuticals | Direktor/Vorstandsmitglied | 01.05.2026 |
Ehemalige bekannte Positionen von Michael Tarnok
| Unternehmen | Position | Ende |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Vorsitzender | 28.03.2024 |
| KERYX BIOPHARMACEUTICALS | Vorstandsvorsitzender | 20.05.2009 |
| PFIZER INC. | Corporate Officer/Principal | 01.01.2007 |
Global Health Council, Inc.
 Global Health Council, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as membership organization supporting and connecting advocates | Direktor/Vorstandsmitglied | - |
Ausbildung von Michael Tarnok
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Dyadic International, Inc.
 Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Health Council, Inc.
Global Health Council, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as membership organization supporting and connecting advocates | Commercial Services |
Ionetix Corp.
Ionetix Corp. Pharmaceuticals: OtherHealth Technology Manufactures radioisotopes and radiopharmaceuticals | Health Technology |
Ionetix, Inc. |
